michael s
(Michael S)
#1
that the ICD should be reserved for those with the worst LV
function. Unfortunately, such patients have competing causes for
mortality such as pump failure and electromechanical
dissociation that are responsible for 50% of deaths. On the other
hand, patients with little or no impairment of LV function and a
single tachyarrhythmic event usually have late and rare recur-
rence leading to sudden death. An ICD can potentially restore
them to near normal life expectancy in the absence of ongoing
myopathic process. The long term studies requiring more than
one life span of an ICD are not available to define the true value of
ICD therapy in such patients.
Although the ability of the implantable cardioverter de-
fibrillator (ICD) to terminate potentially lethal ventricular
arrhythmias is well acknowledged there is less consensus as to
whom should receive an ICD. A good place to start is the
American College of Cardiology/American Heart Association
Practice Guidelines for Arrhythmia Devices.^1 There are three
classes of indications: class one, where there is evidence and/or
general agreement that the treatment is beneficial, useful and
effective; class two, where there is conflicting evidence or a diver-
gence of opinion; and class three, where there is evidence and
general agreement that a treatment is not useful or effective.
The class one indications for ICD implantation are:
11 Cardiac arrest due to VF or VT not due to a transient or reversible
cause.
22 Spontaneous sustained VT.
33 Syncope of undetermined origin with clinically relevant,
haemodynamically significant sustained VT or VF induced at
electrophysiological study when drug therapy is ineffective,
not tolerated or not preferred.
44 Non-sustained VT with coronary disease, prior MI, LV
dysfunction, and inducible VF or sustained VT at electro-
physiological study that is not suppressible by a class I anti-
arrhythmic drug.
The class two indications for ICD implantation are:
11 Cardiac arrest presumed to be due to VF when electro-
physiological testing is precluded by other medical conditions.
22 Severe symptoms attributable to sustained ventricular
arrhythmias while awaiting cardiac transplantation.